Follistim Aq Injection, Solution
NDC Package 78206-129-01
Package Information
Follistim Aq (follitropin) injection is follistim® AQ Cartridge (follitropin beta) injection, is indicated:In Women for:. This formulation utilizes a injection, solution delivery system. Marketed by Organon Llc, this product is identified by NDC 78206-129 and is authorized under FDA application BLA021211.
Identification & Billing
- RxCUI: 1361563 - Follistim AQ 300 UNT in 0.36 ML Cartridge
- RxCUI: 1361563 - 0.36 ML follitropin beta 833 UNT/ML Cartridge [Follistim]
- RxCUI: 1361563 - 0.36 ML Follistim 833 UNT/ML Cartridge
- RxCUI: 1361563 - Follistim AQ 300 IU per 0.36 ML Cartridge
- RxCUI: 1361569 - Follistim AQ 600 UNT in 0.72 ML Cartridge
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 78206 - Organon Llc
- 78206-129 - Follistim Aq
- 78206-129-01 - 1 KIT in 1 CARTON / 1 CARTRIDGE in 1 KIT / .36 mL in 1 CARTRIDGE (78206-129-99)
- 78206-129 - Follistim Aq
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (78206-129). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 78206-129-01 identifies a specific commercial package of 1 kit in 1 carton / 1 cartridge in 1 kit / .36 ml in 1 cartridge (78206-129-99) of Follistim Aq, a human prescription drug labeled by Organon Llc. This injection, solution is formulated for subcutaneous use and contains follitropin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Organon Llc on July 24, 2023. The current certification is valid through December 31, 2027.
How is this Organon Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 78206012901. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.